Akebia Therapeutics, Inc. (AKBA)
1.425
+0.02
(+1.06%)
USD |
NASDAQ |
Apr 22, 16:00
1.425
0.00 (0.00%)
After-Hours: 16:57
Akebia Therapeutics Total Liabilities (Quarterly) : 343.96M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 190.22M |
| MannKind Corp. | 843.20M |
| Ligand Pharmaceuticals, Inc. | 543.42M |
| Ardelyx, Inc. | 335.86M |
| Rhythm Pharmaceuticals, Inc. | 342.12M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 376.56M |
| Shareholders Equity (Quarterly) | 32.61M |
| Debt to Equity Ratio | 6.633 |
| Current Ratio | 1.552 |
| Net Debt Paydown Yield | -1.18% |